Monika Hegi

Dr Monika Hegi is full professor at the University of Lausanne, Switzerland. She has obtained a PhD in natural sciences from the Federal Institute of Technology Zurich (ETHZ), and pursued post-doctoral training in molecular toxicology and molecular carcinogenesis at the National Institute of Environmental Health Sciences (NIEHS), NIH, RTP, NC, USA. Her research focus turned to molecular genetics of brain tumors when she joined the Institute of Neuropathology (USZ) in Zurich in 1993.  

Since 1998 she directs the Laboratory of Brain Tumor Biology and Genetics affiliated with Neurosurgery at the Lausanne University Hospital (CHUV). Taking advantage of the clinical setting her research focus is at the interface of basic and clinicalcancer research. Combining multidimensional molecular analyses of tumors and experimental approaches, her research aims at identifying new molecular targets and predictive factors for response to therapy and outcome in brain tumor patients. She has a special interest in cancer epigenomics and her lab explores strategies for respective combination therapies.

These efforts are in close partnership with clinical research at the Lundin Family Brain Tumour Research Centre, and participation in clinical trials in collaboration with international cooperative groups, in particular the Brain Tumor Group at the European Organisation for Research and Treatment of Cancer (EORTC).